These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 20956343)

  • 1. Domain swapping reveals complement control protein modules critical for imparting cofactor and decay-accelerating activities in vaccinia virus complement control protein.
    Ahmad M; Raut S; Pyaram K; Kamble A; Mullick J; Sahu A
    J Immunol; 2010 Nov; 185(10):6128-37. PubMed ID: 20956343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of complement regulatory domains in vaccinia virus complement control protein.
    Mullick J; Bernet J; Panse Y; Hallihosur S; Singh AK; Sahu A
    J Virol; 2005 Oct; 79(19):12382-93. PubMed ID: 16160165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of a hybrid complement regulatory protein, membrane cofactor protein decay accelerating factor on Chinese hamster ovary. Comparison of its regulatory effect with those of decay accelerating factor and membrane cofactor protein.
    Iwata K; Seya T; Ariga H; Nagasawa S
    J Immunol; 1994 Apr; 152(7):3436-44. PubMed ID: 7511647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of electrostatics on the complement regulatory functions of Kaposica, the complement inhibitor of Kaposi's sarcoma-associated herpesvirus.
    Pyaram K; Kieslich CA; Yadav VN; Morikis D; Sahu A
    J Immunol; 2010 Feb; 184(4):1956-67. PubMed ID: 20089702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of vaccinia virus complement control protein with human complement proteins: factor I-mediated degradation of C3b to iC3b1 inactivates the alternative complement pathway.
    Sahu A; Isaacs SN; Soulika AM; Lambris JD
    J Immunol; 1998 Jun; 160(11):5596-604. PubMed ID: 9605165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Species Specificity of Vaccinia Virus Complement Control Protein for the Bovine Classical Pathway Is Governed Primarily by Direct Interaction of Its Acidic Residues with Factor I.
    Kumar J; Yadav VN; Phulera S; Kamble A; Gautam AK; Panwar HS; Sahu A
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28724763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disabling complement regulatory activities of vaccinia virus complement control protein reduces vaccinia virus pathogenicity.
    Bernet J; Ahmad M; Mullick J; Panse Y; Singh AK; Parab PB; Sahu A
    Vaccine; 2011 Oct; 29(43):7435-43. PubMed ID: 21803094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central modules of the vaccinia virus complement control protein are not in extensive contact.
    Kirkitadze MD; Henderson C; Price NC; Kelly SM; Mullin NP; Parkinson J; Dryden DT; Barlow PN
    Biochem J; 1999 Nov; 344 Pt 1(Pt 1):167-75. PubMed ID: 10548547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathways of complement activation in membranoproliferative glomerulonephritis and allograft rejection.
    Fearon DT; Daha MR; Strom TB; Weiler JM; Carpenter CB; Austen KF
    Transplant Proc; 1977 Mar; 9(1):729-39. PubMed ID: 325806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection of the classical and alternative complement pathway C3 convertases, stabilized by nephritic factors, from decay by the human C3b receptor.
    Fischer E; Kazatchkine MD; Mecarelli-Halbwachs L
    Eur J Immunol; 1984 Dec; 14(12):1111-4. PubMed ID: 6240408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Species selectivity in poxviral complement regulators is dictated by the charge reversal in the central complement control protein modules.
    Yadav VN; Pyaram K; Ahmad M; Sahu A
    J Immunol; 2012 Aug; 189(3):1431-9. PubMed ID: 22732591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of decay-accelerating factor on the assembly of the classical and alternative pathway C3 convertases in the presence of C4 or C3 nephritic factor.
    Ito S; Tamura N; Fujita T
    Immunology; 1989 Dec; 68(4):449-52. PubMed ID: 2481642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping of functional domains in herpesvirus saimiri complement control protein homolog: complement control protein domain 2 is the smallest structural unit displaying cofactor and decay-accelerating activities.
    Singh AK; Yadav VN; Pyaram K; Mullick J; Sahu A
    J Virol; 2009 Oct; 83(19):10299-304. PubMed ID: 19640995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of hot spots in the variola virus complement inhibitor (SPICE) for human complement regulation.
    Yadav VN; Pyaram K; Mullick J; Sahu A
    J Virol; 2008 Apr; 82(7):3283-94. PubMed ID: 18216095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localization of classical and alternative pathway regulatory activity within the decay-accelerating factor.
    Brodbeck WG; Liu D; Sperry J; Mold C; Medof ME
    J Immunol; 1996 Apr; 156(7):2528-33. PubMed ID: 8786315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular engineering of an efficient four-domain DAF-MCP chimera reveals the presence of functional modularity in RCA proteins.
    Panwar HS; Ojha H; Ghosh P; Barage SH; Raut S; Sahu A
    Proc Natl Acad Sci U S A; 2019 May; 116(20):9953-9958. PubMed ID: 31036650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restoration of complement-enhanced neutralization of vaccinia virus virions by novel monoclonal antibodies raised against the vaccinia virus complement control protein.
    Isaacs SN; Argyropoulos E; Sfyroera G; Mohammad S; Lambris JD
    J Virol; 2003 Aug; 77(15):8256-62. PubMed ID: 12857894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The decay accelerating factor mutation I197V found in hemolytic uraemic syndrome does not impair complement regulation.
    Kavanagh D; Burgess R; Spitzer D; Richards A; Diaz-Torres ML; Goodship JA; Hourcade DE; Atkinson JP; Goodship TH
    Mol Immunol; 2007 May; 44(12):3162-7. PubMed ID: 17368771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic analysis of the interactions between vaccinia virus complement control protein and human complement proteins C3b and C4b.
    Bernet J; Mullick J; Panse Y; Parab PB; Sahu A
    J Virol; 2004 Sep; 78(17):9446-57. PubMed ID: 15308738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mouse complement regulatory protein Crry/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein.
    Kim YU; Kinoshita T; Molina H; Hourcade D; Seya T; Wagner LM; Holers VM
    J Exp Med; 1995 Jan; 181(1):151-9. PubMed ID: 7528766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.